These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 14386905)

  • 1. [Studies on arteriosclerosis and endangitis obliterans. VII. Activity of succinoxidase and cytochromoxidase system of skeletal musculare and arteries in peripheral vascular disorders].
    SCHMIDT CG; SCHLIEF H; HILLENBRAND HJ
    Z Gesamte Exp Med; 1955; 125(4):369-78. PubMed ID: 14386905
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on arteriosclerosis and endangitis obliterans. VI. The behavior of succinic dehydrogenase in skeletal musculature in peripheral vascular disorders].
    SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1954; 123(6):491-6. PubMed ID: 13196435
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies on arteriosclerosis and endangitis obliterans. III. Behavior of phosphomonoesterases in skeletal musculature in peripheral vascular disorders].
    SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1954; 122(5):409-15. PubMed ID: 13170019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on arteriosclerosis and endangitis obliterans. VIII. Hexokinase and adenosine triphosphatase in skeletal muscles in peripheral vascular disorders].
    SCHLIEF H; SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1955; 125(4):379-85. PubMed ID: 14386906
    [No Abstract]   [Full Text] [Related]  

  • 5. [Studies on arteriosclerosis and endangitis obliterans. II. Glycogen content of the skeletal musculature in chronic peripheral circulatory disorders].
    SCHMIDT CG; HILLENBRAND HJ
    Z Gesamte Exp Med; 1953; 121(5):480-7. PubMed ID: 13137186
    [No Abstract]   [Full Text] [Related]  

  • 6. [Enzymatic inhibition in the treatment of arteriosclerosis obliterans].
    SARGO LF
    Sem Med; 1960 Sep; 117():1079-82. PubMed ID: 13746496
    [No Abstract]   [Full Text] [Related]  

  • 7. [On protein-bound carbohydrates of the blood serum and intercellular fluid in chronic polyarthritis rheumatica and arteriosclerosis obliterans].
    EMMRICH R; BANNERT N
    Arztl Wochensch; 1960 Feb; 15():115-8. PubMed ID: 13820215
    [No Abstract]   [Full Text] [Related]  

  • 8. [Atrophy of skeletal muscle in peripheral arterial diseases; alterations of some stages of carbohydrate metabolism].
    GAY A; PERIS GC; QUEIROLO C; AGRIFOGLIO G
    Arch Maragliano Patol Clin; 1959 Feb; 15(1):129-36. PubMed ID: 13650871
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytochrome c in skeletal muscles of subjects with peripheral obliterating arteriopathies; study of amputated limbs].
    NIGRO G; FERRANTE G; GALLO D; DE MAGISTRIS A
    Boll Soc Ital Biol Sper; 1958 Apr; 34(8):385-7. PubMed ID: 13536131
    [No Abstract]   [Full Text] [Related]  

  • 10. [On the problem of bone atrophy in endangitis obliterans].
    HILLENBRAND HJ; SCHNEPPER E
    Fortschr Geb Rontgenstr Nuklearmed; 1962 Sep; 97():372-9. PubMed ID: 13907434
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of the serum LDH activity in peripheral circulatory disorders].
    POKORNY J; STUCHLIKOVA E; TENOROVA M; SINDELAROVA I
    Cas Lek Cesk; 1961 Jul; 100():913-6. PubMed ID: 13736620
    [No Abstract]   [Full Text] [Related]  

  • 12. [Chronic obliterating vascular diseases of the periphery in women. II. Arteriosclerosis obliterans].
    GOEBELL H
    Med Welt; 1960 Dec; 52-53():2746-51. PubMed ID: 13706218
    [No Abstract]   [Full Text] [Related]  

  • 13. [New treatments for arteriosclerosis obliterans].
    SARGO LF
    Sem Med; 1960 Oct; 117():1193-8. PubMed ID: 13746497
    [No Abstract]   [Full Text] [Related]  

  • 14. Heat shock proteins in vascular disease--a review.
    Mehta TA; Greenman J; Ettelaie C; Venkatasubramaniam A; Chetter IC; McCollum PT
    Eur J Vasc Endovasc Surg; 2005 Apr; 29(4):395-402. PubMed ID: 15749041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased levels of apoptosis in gastrocnemius skeletal muscle in patients with peripheral arterial disease.
    Mitchell RG; Duscha BD; Robbins JL; Redfern SI; Chung J; Bensimhon DR; Kraus WE; Hiatt WR; Regensteiner JG; Annex BH
    Vasc Med; 2007 Nov; 12(4):285-90. PubMed ID: 18048464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of hematopoietic progenitors in bone marrow from patients with peripheral artery disease.
    Muroi K; Kawano-Yamamoto C; Nagashima T; Mori M; Ozawa K; Matsui K; Murakami Y; Ikeda U
    Leuk Res; 2004 Sep; 28(9):999-1000. PubMed ID: 15234580
    [No Abstract]   [Full Text] [Related]  

  • 17. Sustained peripheral arterial insufficiency durably impairs normal and regenerating skeletal muscle function.
    Hourdé C; Vignaud A; Beurdy I; Martelly I; Keller A; Ferry A
    J Physiol Sci; 2006 Oct; 56(5):361-7. PubMed ID: 17032482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cell therapy in peripheral arterial disease.
    Al Mheid I; Quyyumi AA
    Angiology; 2008 Dec-2009 Jan; 59(6):705-16. PubMed ID: 18818233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hand-arm vibration syndrome and upper limb disorders associated with forestry work].
    Bovenzi M; Rui F; Versini W; Tommasini M; Nataletti P
    Med Lav; 2004; 95(4):282-96. PubMed ID: 15532961
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease.
    Mac Gabhann F; Ji JW; Popel AS
    Ann Biomed Eng; 2007 Jun; 35(6):982-94. PubMed ID: 17436110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.